|
| |
Oystein Fodstad, M.D., Ph.D.
Member Investigator and Distinguished Visiting Professor of Oncologic Sciences
Office:
USA Mitchell Cancer Institute
1660 Springhill Avenue
Mobile, AL. 36604
(251) 445-9862
ofodstad@usouthal.edu
|
Professional Profile
Research Interests:
-Metastasis Research, Diagnosis and Treatment
Honors and Academic Achievements:
-Nordic Cancer Union Research Price, 1980.
-Research supported by The Norwegian Cancer Society, The Norwegian Research Council, and The Regional Health Research Fund (one of seven groups in Norway).
-Norway’s King Olav V’s Outstanding Scientist in Cancer Research Award, 2006
Education:
-Professor II, University of Oslo. (1989)
-Ph.D., Experimental Therapy of Cancer, University of Oslo. (1980)
-M.D., University of Oslo. (1967)
Professional Memberships:
-American Association for Cancer Research
-American Society for Clinical Oncology
-European Association for Cancer Research
Scientific Focus:
Metastasis Research , Diagnosis and Treatment
Selected Publications:
Older highly cited publications related to research focus:
1. Flørenes, V.A., Aamdal, S., Myklebost, O., Mælandsmo, G.M., Bruland. Ø.S., Fodstad, Ø.: Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 52(21): 6088-6091, 1992.(cited more than 193 times)
2. Andreassen, Å., Øyjord, T., Hovig, E., Holm, R., Flørenes, V.A., Nesland, J.M., Myklebost, O., Høie, J., Bruland, Ø.S., Børresen, A-L., Fodstad, Ø.: P53 abnormalities in different subtypes of human sarcomas. Cancer Res. 53: 468-471, 1993.(cited more than 132 times)
3. Ree, A.H., Flørenes, V.A., Berg J.P., Mælandsmo, G.M., Nesland, J.M., Fodstad, Ø.: Clin. Cancer Res. 3: 1623-1628, 1997.(cited more than 114 times)
4. Pantel, K., Cote, R.J., Fodstad, Ø.: Detection and clinical importance of micrometastatic disease. J. Natl. Cancer Inst. 91(13): 1113-1124, 1999.(cited more than 300 times)
Recent Publications:
1. Tveito, S., Mælandsmo, G.M., Rasmussen, H., Høifødt, H.K., Fodstad, Ø. Specific isolation of disseminated cancer cells – a new approach permitting molecular analysis of a pure target cell population. Clin Exp Metastasis, 24(5): 317-27, 2007.
2. Bauer, N.N., Chen, Y-W., Samant, R., Shevde-Samant, L.A., Fodstad, Ø. Rac1-dependent NF?B activity regulates proliferation of aggressive metastatic melanoma. Exp. Cell Res., 313 (18): 3832-3839, 2007.
3. Thies A, Mauer S, Fodstad Ø, Schumacher U. Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice. Br. J Cancer, 9(4): 609-616, 2007.
4. Brunsvig, P. F., Flatmark, K., Aamdal, S., Høifødt, H.K., Le, H., Jakobsen, E., Nesland, J. M., Sandstad, B., Fodstad, Ø. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma. Lung Cancer, 61(2):170-176, 2008.
5. Risberg K, Andersson Y, Fodstad Ø. The melanoma-specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro. Int J Cancer, 125(1): 23-33, 2009.
|
|
|
| |
|